CaƱete, Judy Ann D.
HRN: 21-46-55 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/14/2022
CEFUROXIME 500MG (TAB)
06/14/2022
06/21/2022
PO
500mg
Q12H
2nd Degree RMLE
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes